Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KP.2.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LK.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LB.1.7.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.2.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.2.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LD.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KW.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KR.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.15.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LF.3.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDP.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.31SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.11.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.13.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.32.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.4.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.86.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.34SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.22SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.15SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.58SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.19SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.24SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KQ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.46SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.48SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.47.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.7.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.8.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JH.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDD.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KR.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
MD.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.64.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDP.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KR.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KZ.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KS.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.47SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.23SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.4.2.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LK.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDSSYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LY.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used